Hypertension

>

Latest News

FDA Approves Aprocitentan for Treatment-Resistant HTN: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Aprocitentan for Treatment-Resistant HTN: Daily Dose

March 29th 2024

Your daily dose of the clinical news you may have missed.

FDA Approves Aprocitentan (Tryvio) for Treatment-Resistant Hypertension in Landmark Decision
FDA Approves Aprocitentan (Tryvio) for Treatment-Resistant Hypertension in Landmark Decision

March 20th 2024

Early Detection of CKD Progression in Primary Care: Daily Dose / image credit: ©New Africa/AdobeStock
Early Detection of CKD Progression in Primary Care: Daily Dose

March 12th 2024

Zilebesiran Reduces Hypertension as Addition to Standard of Care in Phase 2 KARDIA-2 Trial / image credit blood pressure cuff and medications: ©Rostick/stock.adobe.com
Zilebesiran Reduces Uncontrolled Hypertension as Addition to Standard of Care in Phase 2 KARDIA-2 Trial

March 5th 2024

Rapid Progression of CKD Can Be Detected Early Using Simple Markers in Primary Care / Image credit kidney disease progression: ©pikovit/stock.adobe.com
Rapid Progression of CKD Can Be Detected Early Using Simple Markers in Primary Care

March 4th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.